Agilent Technologies, Inc. $A Shares Sold by Miracle Mile Advisors LLC

Miracle Mile Advisors LLC cut its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 53.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,257 shares of the medical research company’s stock after selling 4,925 shares during the quarter. Miracle Mile Advisors LLC’s holdings in Agilent Technologies were worth $546,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC increased its position in shares of Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. Focus Partners Advisor Solutions LLC increased its holdings in Agilent Technologies by 9.7% in the first quarter. Focus Partners Advisor Solutions LLC now owns 1,994 shares of the medical research company’s stock valued at $233,000 after buying an additional 176 shares during the last quarter. Federation des caisses Desjardins du Quebec raised its stake in Agilent Technologies by 5.5% in the first quarter. Federation des caisses Desjardins du Quebec now owns 20,656 shares of the medical research company’s stock valued at $2,416,000 after buying an additional 1,085 shares in the last quarter. Advisors Asset Management Inc. raised its stake in Agilent Technologies by 3.9% in the first quarter. Advisors Asset Management Inc. now owns 6,835 shares of the medical research company’s stock valued at $800,000 after buying an additional 258 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. purchased a new stake in Agilent Technologies during the 1st quarter worth about $3,198,000.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. UBS Group increased their price objective on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price for the company. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Finally, Robert W. Baird boosted their price target on shares of Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research report on Tuesday, November 25th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $161.77.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the transaction, the chief executive officer owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the sale, the vice president directly owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 16,401 shares of company stock worth $2,468,962 over the last quarter.

Agilent Technologies Stock Up 1.3%

Shares of NYSE:A opened at $137.82 on Monday. The stock has a market cap of $39.07 billion, a P/E ratio of 30.16, a P/E/G ratio of 4.00 and a beta of 1.29. The firm has a fifty day moving average price of $144.41 and a 200 day moving average price of $131.60. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same period in the previous year, the business posted $1.46 earnings per share. Agilent Technologies’s quarterly revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s payout ratio is 21.66%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.